nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—atherosclerosis	0.58	1	CbGaD
Levonorgestrel—CYP3A4—Ezetimibe—atherosclerosis	0.0198	0.211	CbGbCtD
Levonorgestrel—CYP3A4—Rosuvastatin—atherosclerosis	0.0198	0.211	CbGbCtD
Levonorgestrel—CYP3A4—Simvastatin—atherosclerosis	0.0184	0.196	CbGbCtD
Levonorgestrel—CYP3A4—Lovastatin—atherosclerosis	0.018	0.192	CbGbCtD
Levonorgestrel—CYP3A4—Pravastatin—atherosclerosis	0.018	0.192	CbGbCtD
Levonorgestrel—SHBG—hindlimb—atherosclerosis	0.00634	0.151	CbGeAlD
Levonorgestrel—AR—penis—atherosclerosis	0.00603	0.144	CbGeAlD
Levonorgestrel—PGR—artery—atherosclerosis	0.0035	0.0836	CbGeAlD
Levonorgestrel—PGR—blood vessel—atherosclerosis	0.00273	0.0651	CbGeAlD
Levonorgestrel—SRD5A1—liver—atherosclerosis	0.00229	0.0548	CbGeAlD
Levonorgestrel—ESR1—blood vessel—atherosclerosis	0.00213	0.0509	CbGeAlD
Levonorgestrel—SHBG—connective tissue—atherosclerosis	0.00155	0.0371	CbGeAlD
Levonorgestrel—PGR—connective tissue—atherosclerosis	0.0014	0.0334	CbGeAlD
Levonorgestrel—SHBG—cardiovascular system—atherosclerosis	0.00135	0.0322	CbGeAlD
Levonorgestrel—CYP19A1—connective tissue—atherosclerosis	0.00126	0.03	CbGeAlD
Levonorgestrel—PGR—cardiovascular system—atherosclerosis	0.00122	0.0291	CbGeAlD
Levonorgestrel—SHBG—adipose tissue—atherosclerosis	0.00119	0.0284	CbGeAlD
Levonorgestrel—AR—connective tissue—atherosclerosis	0.00111	0.0266	CbGeAlD
Levonorgestrel—ESR1—connective tissue—atherosclerosis	0.00109	0.0261	CbGeAlD
Levonorgestrel—PGR—adipose tissue—atherosclerosis	0.00107	0.0256	CbGeAlD
Levonorgestrel—AR—cardiovascular system—atherosclerosis	0.000969	0.0231	CbGeAlD
Levonorgestrel—CYP19A1—adipose tissue—atherosclerosis	0.000965	0.0231	CbGeAlD
Levonorgestrel—ESR1—cardiovascular system—atherosclerosis	0.000951	0.0227	CbGeAlD
Levonorgestrel—Danazol—CCL2—atherosclerosis	0.000857	0.122	CrCbGaD
Levonorgestrel—AR—adipose tissue—atherosclerosis	0.000855	0.0204	CbGeAlD
Levonorgestrel—Quinestrol—ESR1—atherosclerosis	0.000844	0.12	CrCbGaD
Levonorgestrel—ESR1—adipose tissue—atherosclerosis	0.000839	0.02	CbGeAlD
Levonorgestrel—SHBG—liver—atherosclerosis	0.000835	0.0199	CbGeAlD
Levonorgestrel—Ethynodiol—ESR1—atherosclerosis	0.000695	0.0985	CrCbGaD
Levonorgestrel—CYP19A1—liver—atherosclerosis	0.000677	0.0162	CbGeAlD
Levonorgestrel—Sweating increased—Pravastatin—atherosclerosis	0.000668	0.00379	CcSEcCtD
Levonorgestrel—Sinusitis—Ezetimibe—atherosclerosis	0.000665	0.00378	CcSEcCtD
Levonorgestrel—Flatulence—Rosuvastatin—atherosclerosis	0.000657	0.00373	CcSEcCtD
Levonorgestrel—Allylestrenol—ESR1—atherosclerosis	0.000656	0.0931	CrCbGaD
Levonorgestrel—Dysuria—Pravastatin—atherosclerosis	0.000641	0.00364	CcSEcCtD
Levonorgestrel—Mestranol—ESR1—atherosclerosis	0.000639	0.0907	CrCbGaD
Levonorgestrel—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000637	0.00362	CcSEcCtD
Levonorgestrel—Sinusitis—Simvastatin—atherosclerosis	0.000635	0.0036	CcSEcCtD
Levonorgestrel—Pharyngitis—Ezetimibe—atherosclerosis	0.000632	0.00359	CcSEcCtD
Levonorgestrel—Desogestrel—ESR1—atherosclerosis	0.000632	0.0896	CrCbGaD
Levonorgestrel—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000626	0.00355	CcSEcCtD
Levonorgestrel—Weight increased—Pravastatin—atherosclerosis	0.000624	0.00354	CcSEcCtD
Levonorgestrel—Weight decreased—Pravastatin—atherosclerosis	0.000621	0.00352	CcSEcCtD
Levonorgestrel—Erythema multiforme—Lovastatin—atherosclerosis	0.000614	0.00348	CcSEcCtD
Levonorgestrel—Depression—Pravastatin—atherosclerosis	0.00061	0.00346	CcSEcCtD
Levonorgestrel—Angioedema—Rosuvastatin—atherosclerosis	0.000609	0.00346	CcSEcCtD
Levonorgestrel—Erythema multiforme—Ezetimibe—atherosclerosis	0.000602	0.00342	CcSEcCtD
Levonorgestrel—AR—liver—atherosclerosis	0.000599	0.0143	CbGeAlD
Levonorgestrel—Urinary tract infection—Pravastatin—atherosclerosis	0.000594	0.00337	CcSEcCtD
Levonorgestrel—Norgestimate—ESR1—atherosclerosis	0.000591	0.0838	CrCbGaD
Levonorgestrel—ESR1—liver—atherosclerosis	0.000588	0.0141	CbGeAlD
Levonorgestrel—Cough—Rosuvastatin—atherosclerosis	0.000582	0.0033	CcSEcCtD
Levonorgestrel—Immune system disorder—Ezetimibe—atherosclerosis	0.000575	0.00326	CcSEcCtD
Levonorgestrel—Erythema multiforme—Simvastatin—atherosclerosis	0.000574	0.00326	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000574	0.00326	CcSEcCtD
Levonorgestrel—Sinusitis—Pravastatin—atherosclerosis	0.000574	0.00326	CcSEcCtD
Levonorgestrel—Alopecia—Lovastatin—atherosclerosis	0.000574	0.00326	CcSEcCtD
Levonorgestrel—Myalgia—Rosuvastatin—atherosclerosis	0.000568	0.00322	CcSEcCtD
Levonorgestrel—Alopecia—Ezetimibe—atherosclerosis	0.000563	0.00319	CcSEcCtD
Levonorgestrel—Haemoglobin—Niacin—atherosclerosis	0.00056	0.00318	CcSEcCtD
Levonorgestrel—Rhinitis—Niacin—atherosclerosis	0.000559	0.00317	CcSEcCtD
Levonorgestrel—Mental disorder—Ezetimibe—atherosclerosis	0.000558	0.00317	CcSEcCtD
Levonorgestrel—Haemorrhage—Niacin—atherosclerosis	0.000558	0.00316	CcSEcCtD
Levonorgestrel—Flatulence—Lovastatin—atherosclerosis	0.000557	0.00316	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Niacin—atherosclerosis	0.000555	0.00315	CcSEcCtD
Levonorgestrel—Malnutrition—Ezetimibe—atherosclerosis	0.000554	0.00315	CcSEcCtD
Levonorgestrel—Erythema—Ezetimibe—atherosclerosis	0.000554	0.00315	CcSEcCtD
Levonorgestrel—Rhinitis—Pravastatin—atherosclerosis	0.00055	0.00312	CcSEcCtD
Levonorgestrel—Back pain—Lovastatin—atherosclerosis	0.000547	0.0031	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Pravastatin—atherosclerosis	0.000546	0.0031	CcSEcCtD
Levonorgestrel—Flatulence—Ezetimibe—atherosclerosis	0.000546	0.0031	CcSEcCtD
Levonorgestrel—Pharyngitis—Pravastatin—atherosclerosis	0.000545	0.00309	CcSEcCtD
Levonorgestrel—Muscle spasms—Lovastatin—atherosclerosis	0.000543	0.00308	CcSEcCtD
Levonorgestrel—Infection—Rosuvastatin—atherosclerosis	0.000541	0.00307	CcSEcCtD
Levonorgestrel—Visual impairment—Niacin—atherosclerosis	0.000537	0.00305	CcSEcCtD
Levonorgestrel—Alopecia—Simvastatin—atherosclerosis	0.000537	0.00305	CcSEcCtD
Levonorgestrel—Back pain—Ezetimibe—atherosclerosis	0.000536	0.00304	CcSEcCtD
Levonorgestrel—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000534	0.00303	CcSEcCtD
Levonorgestrel—Muscle spasms—Ezetimibe—atherosclerosis	0.000533	0.00302	CcSEcCtD
Levonorgestrel—Mental disorder—Simvastatin—atherosclerosis	0.000532	0.00302	CcSEcCtD
Levonorgestrel—Visual impairment—Pravastatin—atherosclerosis	0.000529	0.003	CcSEcCtD
Levonorgestrel—Erythema—Simvastatin—atherosclerosis	0.000529	0.003	CcSEcCtD
Levonorgestrel—Eye disorder—Niacin—atherosclerosis	0.000521	0.00296	CcSEcCtD
Levonorgestrel—Flatulence—Simvastatin—atherosclerosis	0.000521	0.00296	CcSEcCtD
Levonorgestrel—Erythema multiforme—Pravastatin—atherosclerosis	0.000519	0.00295	CcSEcCtD
Levonorgestrel—Angioedema—Lovastatin—atherosclerosis	0.000516	0.00293	CcSEcCtD
Levonorgestrel—Anaemia—Ezetimibe—atherosclerosis	0.000512	0.00291	CcSEcCtD
Levonorgestrel—Etonogestrel—ESR1—atherosclerosis	0.000511	0.0725	CrCbGaD
Levonorgestrel—Cardiac disorder—Pravastatin—atherosclerosis	0.00051	0.00289	CcSEcCtD
Levonorgestrel—Muscle spasms—Simvastatin—atherosclerosis	0.000508	0.00288	CcSEcCtD
Levonorgestrel—Vertigo—Lovastatin—atherosclerosis	0.000508	0.00288	CcSEcCtD
Levonorgestrel—Angioedema—Ezetimibe—atherosclerosis	0.000507	0.00287	CcSEcCtD
Levonorgestrel—Arrhythmia—Niacin—atherosclerosis	0.000498	0.00283	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000496	0.00281	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR2—atherosclerosis	0.000495	0.0702	CrCbGaD
Levonorgestrel—Alopecia—Niacin—atherosclerosis	0.000493	0.0028	CcSEcCtD
Levonorgestrel—Insomnia—Rosuvastatin—atherosclerosis	0.000492	0.00279	CcSEcCtD
Levonorgestrel—Arrhythmia—Pravastatin—atherosclerosis	0.00049	0.00278	CcSEcCtD
Levonorgestrel—Palpitations—Ezetimibe—atherosclerosis	0.00049	0.00278	CcSEcCtD
Levonorgestrel—Anaemia—Simvastatin—atherosclerosis	0.000489	0.00277	CcSEcCtD
Levonorgestrel—Erythema—Niacin—atherosclerosis	0.000485	0.00275	CcSEcCtD
Levonorgestrel—Malnutrition—Niacin—atherosclerosis	0.000485	0.00275	CcSEcCtD
Levonorgestrel—Alopecia—Pravastatin—atherosclerosis	0.000485	0.00275	CcSEcCtD
Levonorgestrel—Cough—Ezetimibe—atherosclerosis	0.000484	0.00275	CcSEcCtD
Levonorgestrel—Angioedema—Simvastatin—atherosclerosis	0.000483	0.00274	CcSEcCtD
Levonorgestrel—Chest pain—Lovastatin—atherosclerosis	0.000481	0.00273	CcSEcCtD
Levonorgestrel—Myalgia—Lovastatin—atherosclerosis	0.000481	0.00273	CcSEcCtD
Levonorgestrel—Anxiety—Lovastatin—atherosclerosis	0.000479	0.00272	CcSEcCtD
Levonorgestrel—Dyspepsia—Rosuvastatin—atherosclerosis	0.000479	0.00272	CcSEcCtD
Levonorgestrel—Hypertension—Ezetimibe—atherosclerosis	0.000479	0.00272	CcSEcCtD
Levonorgestrel—Flatulence—Niacin—atherosclerosis	0.000478	0.00271	CcSEcCtD
Levonorgestrel—Tension—Niacin—atherosclerosis	0.000476	0.0027	CcSEcCtD
Levonorgestrel—Discomfort—Lovastatin—atherosclerosis	0.000475	0.0027	CcSEcCtD
Levonorgestrel—Vertigo—Simvastatin—atherosclerosis	0.000475	0.0027	CcSEcCtD
Levonorgestrel—Myalgia—Ezetimibe—atherosclerosis	0.000472	0.00268	CcSEcCtD
Levonorgestrel—Chest pain—Ezetimibe—atherosclerosis	0.000472	0.00268	CcSEcCtD
Levonorgestrel—Nervousness—Niacin—atherosclerosis	0.000471	0.00268	CcSEcCtD
Levonorgestrel—Flatulence—Pravastatin—atherosclerosis	0.000471	0.00267	CcSEcCtD
Levonorgestrel—Tension—Pravastatin—atherosclerosis	0.000469	0.00266	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000469	0.00266	CcSEcCtD
Levonorgestrel—Muscle spasms—Niacin—atherosclerosis	0.000467	0.00265	CcSEcCtD
Levonorgestrel—Discomfort—Ezetimibe—atherosclerosis	0.000466	0.00265	CcSEcCtD
Levonorgestrel—Constipation—Rosuvastatin—atherosclerosis	0.000465	0.00264	CcSEcCtD
Levonorgestrel—Pain—Rosuvastatin—atherosclerosis	0.000465	0.00264	CcSEcCtD
Levonorgestrel—Nervousness—Pravastatin—atherosclerosis	0.000464	0.00263	CcSEcCtD
Levonorgestrel—Muscle spasms—Pravastatin—atherosclerosis	0.000459	0.00261	CcSEcCtD
Levonorgestrel—Infection—Lovastatin—atherosclerosis	0.000458	0.0026	CcSEcCtD
Levonorgestrel—Chest pain—Simvastatin—atherosclerosis	0.00045	0.00255	CcSEcCtD
Levonorgestrel—Myalgia—Simvastatin—atherosclerosis	0.00045	0.00255	CcSEcCtD
Levonorgestrel—Infection—Ezetimibe—atherosclerosis	0.000449	0.00255	CcSEcCtD
Levonorgestrel—Anxiety—Simvastatin—atherosclerosis	0.000448	0.00255	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000445	0.00253	CcSEcCtD
Levonorgestrel—Discomfort—Simvastatin—atherosclerosis	0.000445	0.00252	CcSEcCtD
Levonorgestrel—Nervous system disorder—Ezetimibe—atherosclerosis	0.000444	0.00252	CcSEcCtD
Levonorgestrel—Angioedema—Niacin—atherosclerosis	0.000444	0.00252	CcSEcCtD
Levonorgestrel—Anaemia—Pravastatin—atherosclerosis	0.000442	0.00251	CcSEcCtD
Levonorgestrel—Anorexia—Lovastatin—atherosclerosis	0.00044	0.0025	CcSEcCtD
Levonorgestrel—Skin disorder—Ezetimibe—atherosclerosis	0.000439	0.00249	CcSEcCtD
Levonorgestrel—Angioedema—Pravastatin—atherosclerosis	0.000437	0.00248	CcSEcCtD
Levonorgestrel—Vertigo—Niacin—atherosclerosis	0.000436	0.00248	CcSEcCtD
Levonorgestrel—Syncope—Niacin—atherosclerosis	0.000435	0.00247	CcSEcCtD
Levonorgestrel—Urticaria—Rosuvastatin—atherosclerosis	0.000432	0.00245	CcSEcCtD
Levonorgestrel—Oedema—Simvastatin—atherosclerosis	0.000431	0.00245	CcSEcCtD
Levonorgestrel—Abdominal pain—Rosuvastatin—atherosclerosis	0.00043	0.00244	CcSEcCtD
Levonorgestrel—Vertigo—Pravastatin—atherosclerosis	0.000429	0.00244	CcSEcCtD
Levonorgestrel—Palpitations—Niacin—atherosclerosis	0.000429	0.00243	CcSEcCtD
Levonorgestrel—Infection—Simvastatin—atherosclerosis	0.000429	0.00243	CcSEcCtD
Levonorgestrel—Loss of consciousness—Niacin—atherosclerosis	0.000427	0.00242	CcSEcCtD
Levonorgestrel—Cough—Niacin—atherosclerosis	0.000424	0.0024	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00042	0.00238	CcSEcCtD
Levonorgestrel—Insomnia—Lovastatin—atherosclerosis	0.000417	0.00237	CcSEcCtD
Levonorgestrel—Cough—Pravastatin—atherosclerosis	0.000417	0.00237	CcSEcCtD
Levonorgestrel—Myalgia—Niacin—atherosclerosis	0.000413	0.00235	CcSEcCtD
Levonorgestrel—Hypertension—Pravastatin—atherosclerosis	0.000413	0.00234	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000412	0.00234	CcSEcCtD
Levonorgestrel—Anorexia—Simvastatin—atherosclerosis	0.000411	0.00233	CcSEcCtD
Levonorgestrel—Dyspnoea—Lovastatin—atherosclerosis	0.000411	0.00233	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00041	0.00233	CcSEcCtD
Levonorgestrel—Insomnia—Ezetimibe—atherosclerosis	0.000409	0.00232	CcSEcCtD
Levonorgestrel—Chest pain—Pravastatin—atherosclerosis	0.000407	0.00231	CcSEcCtD
Levonorgestrel—Myalgia—Pravastatin—atherosclerosis	0.000407	0.00231	CcSEcCtD
Levonorgestrel—Dyspepsia—Lovastatin—atherosclerosis	0.000406	0.0023	CcSEcCtD
Levonorgestrel—Anxiety—Pravastatin—atherosclerosis	0.000405	0.0023	CcSEcCtD
Levonorgestrel—Dyspnoea—Ezetimibe—atherosclerosis	0.000403	0.00229	CcSEcCtD
Levonorgestrel—Discomfort—Pravastatin—atherosclerosis	0.000402	0.00228	CcSEcCtD
Levonorgestrel—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000401	0.00228	CcSEcCtD
Levonorgestrel—Decreased appetite—Lovastatin—atherosclerosis	0.000401	0.00228	CcSEcCtD
Levonorgestrel—Dyspepsia—Ezetimibe—atherosclerosis	0.000398	0.00226	CcSEcCtD
Levonorgestrel—Fatigue—Lovastatin—atherosclerosis	0.000398	0.00226	CcSEcCtD
Levonorgestrel—Oedema—Niacin—atherosclerosis	0.000396	0.00225	CcSEcCtD
Levonorgestrel—Constipation—Lovastatin—atherosclerosis	0.000394	0.00224	CcSEcCtD
Levonorgestrel—Pain—Lovastatin—atherosclerosis	0.000394	0.00224	CcSEcCtD
Levonorgestrel—Decreased appetite—Ezetimibe—atherosclerosis	0.000393	0.00223	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000393	0.00223	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000391	0.00222	CcSEcCtD
Levonorgestrel—Asthenia—Rosuvastatin—atherosclerosis	0.00039	0.00222	CcSEcCtD
Levonorgestrel—Insomnia—Simvastatin—atherosclerosis	0.00039	0.00221	CcSEcCtD
Levonorgestrel—Oedema—Pravastatin—atherosclerosis	0.00039	0.00221	CcSEcCtD
Levonorgestrel—Fatigue—Ezetimibe—atherosclerosis	0.00039	0.00221	CcSEcCtD
Levonorgestrel—Shock—Niacin—atherosclerosis	0.00039	0.00221	CcSEcCtD
Levonorgestrel—Infection—Pravastatin—atherosclerosis	0.000387	0.0022	CcSEcCtD
Levonorgestrel—Constipation—Ezetimibe—atherosclerosis	0.000387	0.0022	CcSEcCtD
Levonorgestrel—Pain—Ezetimibe—atherosclerosis	0.000387	0.0022	CcSEcCtD
Levonorgestrel—Pruritus—Rosuvastatin—atherosclerosis	0.000385	0.00219	CcSEcCtD
Levonorgestrel—Skin disorder—Niacin—atherosclerosis	0.000385	0.00218	CcSEcCtD
Levonorgestrel—Dyspnoea—Simvastatin—atherosclerosis	0.000385	0.00218	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Niacin—atherosclerosis	0.000383	0.00217	CcSEcCtD
Levonorgestrel—Dyspepsia—Simvastatin—atherosclerosis	0.00038	0.00216	CcSEcCtD
Levonorgestrel—Anorexia—Niacin—atherosclerosis	0.000378	0.00214	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000377	0.00214	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Pravastatin—atherosclerosis	0.000377	0.00214	CcSEcCtD
Levonorgestrel—Decreased appetite—Simvastatin—atherosclerosis	0.000375	0.00213	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000372	0.00211	CcSEcCtD
Levonorgestrel—Diarrhoea—Rosuvastatin—atherosclerosis	0.000372	0.00211	CcSEcCtD
Levonorgestrel—Fatigue—Simvastatin—atherosclerosis	0.000372	0.00211	CcSEcCtD
Levonorgestrel—Anorexia—Pravastatin—atherosclerosis	0.000372	0.00211	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00037	0.0021	CcSEcCtD
Levonorgestrel—Constipation—Simvastatin—atherosclerosis	0.000369	0.00209	CcSEcCtD
Levonorgestrel—Pain—Simvastatin—atherosclerosis	0.000369	0.00209	CcSEcCtD
Levonorgestrel—Urticaria—Lovastatin—atherosclerosis	0.000366	0.00208	CcSEcCtD
Levonorgestrel—Abdominal pain—Lovastatin—atherosclerosis	0.000365	0.00207	CcSEcCtD
Levonorgestrel—Body temperature increased—Lovastatin—atherosclerosis	0.000365	0.00207	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000361	0.00205	CcSEcCtD
Levonorgestrel—Dizziness—Rosuvastatin—atherosclerosis	0.00036	0.00204	CcSEcCtD
Levonorgestrel—Urticaria—Ezetimibe—atherosclerosis	0.000359	0.00204	CcSEcCtD
Levonorgestrel—Insomnia—Niacin—atherosclerosis	0.000358	0.00203	CcSEcCtD
Levonorgestrel—Body temperature increased—Ezetimibe—atherosclerosis	0.000358	0.00203	CcSEcCtD
Levonorgestrel—Abdominal pain—Ezetimibe—atherosclerosis	0.000358	0.00203	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000355	0.00202	CcSEcCtD
Levonorgestrel—Dyspnoea—Niacin—atherosclerosis	0.000353	0.002	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000353	0.002	CcSEcCtD
Levonorgestrel—Insomnia—Pravastatin—atherosclerosis	0.000353	0.002	CcSEcCtD
Levonorgestrel—Somnolence—Niacin—atherosclerosis	0.000352	0.002	CcSEcCtD
Levonorgestrel—Dyspepsia—Niacin—atherosclerosis	0.000349	0.00198	CcSEcCtD
Levonorgestrel—Dyspnoea—Pravastatin—atherosclerosis	0.000348	0.00197	CcSEcCtD
Levonorgestrel—Decreased appetite—Niacin—atherosclerosis	0.000344	0.00195	CcSEcCtD
Levonorgestrel—Dyspepsia—Pravastatin—atherosclerosis	0.000343	0.00195	CcSEcCtD
Levonorgestrel—Rash—Rosuvastatin—atherosclerosis	0.000343	0.00195	CcSEcCtD
Levonorgestrel—Dermatitis—Rosuvastatin—atherosclerosis	0.000343	0.00195	CcSEcCtD
Levonorgestrel—Urticaria—Simvastatin—atherosclerosis	0.000343	0.00195	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Niacin—atherosclerosis	0.000342	0.00194	CcSEcCtD
Levonorgestrel—Body temperature increased—Simvastatin—atherosclerosis	0.000341	0.00194	CcSEcCtD
Levonorgestrel—Abdominal pain—Simvastatin—atherosclerosis	0.000341	0.00194	CcSEcCtD
Levonorgestrel—Headache—Rosuvastatin—atherosclerosis	0.000341	0.00194	CcSEcCtD
Levonorgestrel—Hypersensitivity—Lovastatin—atherosclerosis	0.00034	0.00193	CcSEcCtD
Levonorgestrel—Decreased appetite—Pravastatin—atherosclerosis	0.000339	0.00192	CcSEcCtD
Levonorgestrel—Pain—Niacin—atherosclerosis	0.000339	0.00192	CcSEcCtD
Levonorgestrel—Fatigue—Pravastatin—atherosclerosis	0.000336	0.00191	CcSEcCtD
Levonorgestrel—Pain—Pravastatin—atherosclerosis	0.000334	0.00189	CcSEcCtD
Levonorgestrel—Constipation—Pravastatin—atherosclerosis	0.000334	0.00189	CcSEcCtD
Levonorgestrel—Hypersensitivity—Ezetimibe—atherosclerosis	0.000333	0.00189	CcSEcCtD
Levonorgestrel—Asthenia—Lovastatin—atherosclerosis	0.000331	0.00188	CcSEcCtD
Levonorgestrel—Danazol—ESR1—atherosclerosis	0.000329	0.0467	CrCbGaD
Levonorgestrel—CYP3A4—liver—atherosclerosis	0.000328	0.00784	CbGeAlD
Levonorgestrel—Pruritus—Lovastatin—atherosclerosis	0.000326	0.00185	CcSEcCtD
Levonorgestrel—Asthenia—Ezetimibe—atherosclerosis	0.000325	0.00184	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Niacin—atherosclerosis	0.000324	0.00184	CcSEcCtD
Levonorgestrel—Nausea—Rosuvastatin—atherosclerosis	0.000323	0.00183	CcSEcCtD
Levonorgestrel—Pruritus—Ezetimibe—atherosclerosis	0.00032	0.00182	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000319	0.00181	CcSEcCtD
Levonorgestrel—Hypersensitivity—Simvastatin—atherosclerosis	0.000318	0.0018	CcSEcCtD
Levonorgestrel—Diarrhoea—Lovastatin—atherosclerosis	0.000316	0.00179	CcSEcCtD
Levonorgestrel—Urticaria—Niacin—atherosclerosis	0.000315	0.00179	CcSEcCtD
Levonorgestrel—Body temperature increased—Niacin—atherosclerosis	0.000313	0.00178	CcSEcCtD
Levonorgestrel—Abdominal pain—Niacin—atherosclerosis	0.000313	0.00178	CcSEcCtD
Levonorgestrel—Urticaria—Pravastatin—atherosclerosis	0.00031	0.00176	CcSEcCtD
Levonorgestrel—Asthenia—Simvastatin—atherosclerosis	0.00031	0.00176	CcSEcCtD
Levonorgestrel—Diarrhoea—Ezetimibe—atherosclerosis	0.00031	0.00176	CcSEcCtD
Levonorgestrel—Abdominal pain—Pravastatin—atherosclerosis	0.000308	0.00175	CcSEcCtD
Levonorgestrel—Body temperature increased—Pravastatin—atherosclerosis	0.000308	0.00175	CcSEcCtD
Levonorgestrel—Pruritus—Simvastatin—atherosclerosis	0.000305	0.00173	CcSEcCtD
Levonorgestrel—Dizziness—Lovastatin—atherosclerosis	0.000305	0.00173	CcSEcCtD
Levonorgestrel—Ethinyl Estradiol—ESR1—atherosclerosis	0.000305	0.0432	CrCbGaD
Levonorgestrel—Dizziness—Ezetimibe—atherosclerosis	0.000299	0.0017	CcSEcCtD
Levonorgestrel—Diarrhoea—Simvastatin—atherosclerosis	0.000295	0.00168	CcSEcCtD
Levonorgestrel—Vomiting—Lovastatin—atherosclerosis	0.000293	0.00166	CcSEcCtD
Levonorgestrel—Hypersensitivity—Niacin—atherosclerosis	0.000292	0.00166	CcSEcCtD
Levonorgestrel—Rash—Lovastatin—atherosclerosis	0.000291	0.00165	CcSEcCtD
Levonorgestrel—Dermatitis—Lovastatin—atherosclerosis	0.000291	0.00165	CcSEcCtD
Levonorgestrel—Headache—Lovastatin—atherosclerosis	0.000289	0.00164	CcSEcCtD
Levonorgestrel—Vomiting—Ezetimibe—atherosclerosis	0.000288	0.00163	CcSEcCtD
Levonorgestrel—Hypersensitivity—Pravastatin—atherosclerosis	0.000287	0.00163	CcSEcCtD
Levonorgestrel—Dizziness—Simvastatin—atherosclerosis	0.000285	0.00162	CcSEcCtD
Levonorgestrel—Rash—Ezetimibe—atherosclerosis	0.000285	0.00162	CcSEcCtD
Levonorgestrel—Dermatitis—Ezetimibe—atherosclerosis	0.000285	0.00162	CcSEcCtD
Levonorgestrel—Asthenia—Niacin—atherosclerosis	0.000284	0.00161	CcSEcCtD
Levonorgestrel—Headache—Ezetimibe—atherosclerosis	0.000283	0.00161	CcSEcCtD
Levonorgestrel—Pruritus—Niacin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Levonorgestrel—Asthenia—Pravastatin—atherosclerosis	0.00028	0.00159	CcSEcCtD
Levonorgestrel—Pruritus—Pravastatin—atherosclerosis	0.000276	0.00157	CcSEcCtD
Levonorgestrel—Vomiting—Simvastatin—atherosclerosis	0.000274	0.00156	CcSEcCtD
Levonorgestrel—Nausea—Lovastatin—atherosclerosis	0.000274	0.00155	CcSEcCtD
Levonorgestrel—Rash—Simvastatin—atherosclerosis	0.000272	0.00154	CcSEcCtD
Levonorgestrel—Dermatitis—Simvastatin—atherosclerosis	0.000272	0.00154	CcSEcCtD
Levonorgestrel—Diarrhoea—Niacin—atherosclerosis	0.000271	0.00154	CcSEcCtD
Levonorgestrel—Headache—Simvastatin—atherosclerosis	0.00027	0.00153	CcSEcCtD
Levonorgestrel—Nausea—Ezetimibe—atherosclerosis	0.000269	0.00153	CcSEcCtD
Levonorgestrel—Diarrhoea—Pravastatin—atherosclerosis	0.000267	0.00151	CcSEcCtD
Levonorgestrel—Dizziness—Niacin—atherosclerosis	0.000262	0.00149	CcSEcCtD
Levonorgestrel—Dizziness—Pravastatin—atherosclerosis	0.000258	0.00146	CcSEcCtD
Levonorgestrel—Nausea—Simvastatin—atherosclerosis	0.000256	0.00145	CcSEcCtD
Levonorgestrel—Vomiting—Niacin—atherosclerosis	0.000252	0.00143	CcSEcCtD
Levonorgestrel—Rash—Niacin—atherosclerosis	0.00025	0.00142	CcSEcCtD
Levonorgestrel—Dermatitis—Niacin—atherosclerosis	0.00025	0.00142	CcSEcCtD
Levonorgestrel—Headache—Niacin—atherosclerosis	0.000248	0.00141	CcSEcCtD
Levonorgestrel—Vomiting—Pravastatin—atherosclerosis	0.000248	0.00141	CcSEcCtD
Levonorgestrel—Rash—Pravastatin—atherosclerosis	0.000246	0.0014	CcSEcCtD
Levonorgestrel—Dermatitis—Pravastatin—atherosclerosis	0.000246	0.00139	CcSEcCtD
Levonorgestrel—Headache—Pravastatin—atherosclerosis	0.000244	0.00139	CcSEcCtD
Levonorgestrel—Nausea—Niacin—atherosclerosis	0.000235	0.00134	CcSEcCtD
Levonorgestrel—Nausea—Pravastatin—atherosclerosis	0.000232	0.00131	CcSEcCtD
Levonorgestrel—Progesterone—ESR1—atherosclerosis	0.000171	0.0242	CrCbGaD
Levonorgestrel—Norethindrone—ALB—atherosclerosis	0.00013	0.0185	CrCbGaD
Levonorgestrel—Methyltestosterone—ALB—atherosclerosis	0.000124	0.0176	CrCbGaD
Levonorgestrel—Testosterone—ALB—atherosclerosis	7.19e-05	0.0102	CrCbGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.06e-05	0.000499	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.01e-05	0.000494	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRH1—atherosclerosis	5e-05	0.000493	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	4.93e-05	0.000485	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.91e-05	0.000484	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CNR2—atherosclerosis	4.9e-05	0.000483	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HSPA1B—atherosclerosis	4.88e-05	0.000481	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.8e-05	0.000473	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP27A1—atherosclerosis	4.76e-05	0.000469	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—PPARG—atherosclerosis	4.73e-05	0.000466	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.69e-05	0.000462	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.57e-05	0.000451	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.55e-05	0.000448	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	4.55e-05	0.000448	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALOX15—atherosclerosis	4.52e-05	0.000445	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALOX5AP—atherosclerosis	4.52e-05	0.000445	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA2—atherosclerosis	4.52e-05	0.000445	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PLA2G2A—atherosclerosis	4.52e-05	0.000445	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCG5—atherosclerosis	4.46e-05	0.00044	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.46e-05	0.000439	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	4.41e-05	0.000435	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VWF—atherosclerosis	4.36e-05	0.00043	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SIRT1—atherosclerosis	4.35e-05	0.000429	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PARP1—atherosclerosis	4.35e-05	0.000429	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOC3—atherosclerosis	4.34e-05	0.000428	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LDLR—atherosclerosis	4.31e-05	0.000425	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPA—atherosclerosis	4.31e-05	0.000425	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.3e-05	0.000424	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.26e-05	0.00042	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL3—atherosclerosis	4.21e-05	0.000415	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.17e-05	0.000411	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—BGN—atherosclerosis	4.17e-05	0.000411	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.14e-05	0.000408	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA5—atherosclerosis	4.13e-05	0.000407	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR2—atherosclerosis	4.12e-05	0.000406	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCF1—atherosclerosis	4.03e-05	0.000397	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.01e-05	0.000395	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PLA2G1B—atherosclerosis	3.98e-05	0.000392	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.93e-05	0.000387	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA4—atherosclerosis	3.93e-05	0.000387	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.91e-05	0.000386	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	3.9e-05	0.000384	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.89e-05	0.000384	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.89e-05	0.000383	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALOX5—atherosclerosis	3.84e-05	0.000378	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR2—atherosclerosis	3.81e-05	0.000375	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EDNRA—atherosclerosis	3.81e-05	0.000375	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CYBA—atherosclerosis	3.79e-05	0.000374	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—IL6—atherosclerosis	3.78e-05	0.000372	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.77e-05	0.000371	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HSPA1B—atherosclerosis	3.76e-05	0.00037	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PARP1—atherosclerosis	3.71e-05	0.000366	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLAT—atherosclerosis	3.71e-05	0.000366	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GHRL—atherosclerosis	3.71e-05	0.000366	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	3.65e-05	0.000359	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.63e-05	0.000358	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARA—atherosclerosis	3.62e-05	0.000357	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL4—atherosclerosis	3.62e-05	0.000357	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.58e-05	0.000353	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.55e-05	0.00035	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.5e-05	0.000345	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	3.48e-05	0.000343	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NAMPT—atherosclerosis	3.44e-05	0.000339	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.42e-05	0.000337	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LIPC—atherosclerosis	3.42e-05	0.000337	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOC3—atherosclerosis	3.4e-05	0.000335	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LDLR—atherosclerosis	3.38e-05	0.000333	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA2—atherosclerosis	3.38e-05	0.000333	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PARP1—atherosclerosis	3.35e-05	0.00033	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SIRT1—atherosclerosis	3.32e-05	0.000327	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CETP—atherosclerosis	3.3e-05	0.000325	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	3.28e-05	0.000324	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—ESR1—atherosclerosis	3.28e-05	0.000323	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KNG1—atherosclerosis	3.26e-05	0.000321	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGTR1—atherosclerosis	3.24e-05	0.000319	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—UTS2—atherosclerosis	3.22e-05	0.000318	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—ESR2—atherosclerosis	3.17e-05	0.000313	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SCARB1—atherosclerosis	3.16e-05	0.000312	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLG—atherosclerosis	3.16e-05	0.000311	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	3.09e-05	0.000305	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASR—atherosclerosis	3.09e-05	0.000305	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.08e-05	0.000303	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	3.03e-05	0.000299	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—PPARG—atherosclerosis	2.99e-05	0.000295	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SOCS3—atherosclerosis	2.99e-05	0.000295	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMGCR—atherosclerosis	2.99e-05	0.000294	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.9e-05	0.000286	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP3—atherosclerosis	2.89e-05	0.000284	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CNR2—atherosclerosis	2.87e-05	0.000283	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF2—atherosclerosis	2.87e-05	0.000283	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOB—atherosclerosis	2.79e-05	0.000275	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—atherosclerosis	2.78e-05	0.000274	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARA—atherosclerosis	2.76e-05	0.000272	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EDN1—atherosclerosis	2.75e-05	0.000271	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL5—atherosclerosis	2.72e-05	0.000268	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—SERPINE1—atherosclerosis	2.69e-05	0.000266	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.69e-05	0.000265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LPL—atherosclerosis	2.66e-05	0.000263	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCA1—atherosclerosis	2.66e-05	0.000262	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCG—atherosclerosis	2.59e-05	0.000255	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.57e-05	0.000254	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VWF—atherosclerosis	2.56e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SIRT1—atherosclerosis	2.55e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOC3—atherosclerosis	2.55e-05	0.000251	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LDLR—atherosclerosis	2.53e-05	0.000249	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SPP1—atherosclerosis	2.52e-05	0.000249	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—ESR1—atherosclerosis	2.5e-05	0.000246	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL3—atherosclerosis	2.47e-05	0.000244	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLTP—atherosclerosis	2.42e-05	0.000239	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCF1—atherosclerosis	2.37e-05	0.000233	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PDGFB—atherosclerosis	2.33e-05	0.00023	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—atherosclerosis	2.28e-05	0.000225	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—PPARG—atherosclerosis	2.28e-05	0.000225	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGT—atherosclerosis	2.28e-05	0.000225	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDNRA—atherosclerosis	2.23e-05	0.00022	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR2—atherosclerosis	2.23e-05	0.00022	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—LEP—atherosclerosis	2.23e-05	0.00022	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—atherosclerosis	2.23e-05	0.00022	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CYBA—atherosclerosis	2.23e-05	0.000219	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—atherosclerosis	2.21e-05	0.000218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOA1—atherosclerosis	2.21e-05	0.000218	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOB—atherosclerosis	2.19e-05	0.000216	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PARP1—atherosclerosis	2.18e-05	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLAT—atherosclerosis	2.18e-05	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GHRL—atherosclerosis	2.18e-05	0.000215	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ESR1—atherosclerosis	2.13e-05	0.00021	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—atherosclerosis	2.13e-05	0.00021	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARA—atherosclerosis	2.12e-05	0.000209	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—F2—atherosclerosis	2.11e-05	0.000208	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.1e-05	0.000207	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.1e-05	0.000207	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—LPL—atherosclerosis	2.09e-05	0.000206	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SERPINE1—atherosclerosis	2.05e-05	0.000202	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—atherosclerosis	2.04e-05	0.000201	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PIK3CG—atherosclerosis	2.01e-05	0.000199	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CD36—atherosclerosis	1.98e-05	0.000196	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KNG1—atherosclerosis	1.91e-05	0.000188	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—INS—atherosclerosis	1.91e-05	0.000188	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGTR1—atherosclerosis	1.9e-05	0.000187	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—atherosclerosis	1.88e-05	0.000185	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—atherosclerosis	1.88e-05	0.000185	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLG—atherosclerosis	1.85e-05	0.000183	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IGF1—atherosclerosis	1.84e-05	0.000182	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARA—atherosclerosis	1.84e-05	0.000182	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AGT—atherosclerosis	1.79e-05	0.000176	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—PPARG—atherosclerosis	1.76e-05	0.000173	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS3—atherosclerosis	1.75e-05	0.000173	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAPK3—atherosclerosis	1.75e-05	0.000173	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SERPINE1—atherosclerosis	1.75e-05	0.000173	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—atherosclerosis	1.75e-05	0.000173	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—atherosclerosis	1.73e-05	0.000171	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOA1—atherosclerosis	1.73e-05	0.000171	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP3—atherosclerosis	1.69e-05	0.000167	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF2—atherosclerosis	1.69e-05	0.000166	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—atherosclerosis	1.67e-05	0.000165	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.66e-05	0.000163	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOB—atherosclerosis	1.64e-05	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDN1—atherosclerosis	1.61e-05	0.000159	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL5—atherosclerosis	1.6e-05	0.000158	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SERPINE1—atherosclerosis	1.58e-05	0.000156	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PIK3CG—atherosclerosis	1.58e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LPL—atherosclerosis	1.56e-05	0.000154	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FABP4—atherosclerosis	1.56e-05	0.000154	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LCAT—atherosclerosis	1.56e-05	0.000154	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA4—atherosclerosis	1.53e-05	0.000151	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PPARG—atherosclerosis	1.52e-05	0.00015	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCG—atherosclerosis	1.52e-05	0.00015	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.5e-05	0.000148	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—INS—atherosclerosis	1.5e-05	0.000147	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL8—atherosclerosis	1.48e-05	0.000146	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SPP1—atherosclerosis	1.48e-05	0.000146	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.39e-05	0.000137	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—atherosclerosis	1.37e-05	0.000135	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.37e-05	0.000135	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—atherosclerosis	1.34e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGT—atherosclerosis	1.34e-05	0.000132	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAPK3—atherosclerosis	1.34e-05	0.000132	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NFKB1—atherosclerosis	1.33e-05	0.000131	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.32e-05	0.00013	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA2—atherosclerosis	1.32e-05	0.00013	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.32e-05	0.00013	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.32e-05	0.00013	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LEP—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK8—atherosclerosis	1.31e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.3e-05	0.000128	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.3e-05	0.000128	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.3e-05	0.000128	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPA—atherosclerosis	1.26e-05	0.000124	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—F2—atherosclerosis	1.24e-05	0.000122	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BGN—atherosclerosis	1.22e-05	0.00012	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA5—atherosclerosis	1.21e-05	0.000119	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—atherosclerosis	1.2e-05	0.000119	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—atherosclerosis	1.2e-05	0.000118	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—STAT3—atherosclerosis	1.19e-05	0.000118	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.18e-05	0.000117	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—atherosclerosis	1.18e-05	0.000117	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.16e-05	0.000114	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAPK3—atherosclerosis	1.14e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.12e-05	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—INS—atherosclerosis	1.12e-05	0.00011	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—atherosclerosis	1.11e-05	0.000109	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—atherosclerosis	1.1e-05	0.000109	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IGF1—atherosclerosis	1.08e-05	0.000107	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAPK3—atherosclerosis	1.03e-05	0.000101	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.03e-05	0.000101	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NAMPT—atherosclerosis	1e-05	9.9e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LIPC—atherosclerosis	9.99e-06	9.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOC3—atherosclerosis	9.92e-06	9.78e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LDLR—atherosclerosis	9.86e-06	9.72e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—atherosclerosis	9.82e-06	9.68e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CETP—atherosclerosis	9.63e-06	9.5e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.23e-06	9.09e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—atherosclerosis	9.01e-06	8.88e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.71e-06	8.59e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL8—atherosclerosis	8.71e-06	8.58e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6—atherosclerosis	8.33e-06	8.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—atherosclerosis	7.88e-06	7.76e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NFKB1—atherosclerosis	7.79e-06	7.68e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.77e-06	7.65e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—atherosclerosis	7.69e-06	7.58e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK8—atherosclerosis	7.66e-06	7.55e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—atherosclerosis	7.07e-06	6.97e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—STAT3—atherosclerosis	7e-06	6.9e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—atherosclerosis	6.94e-06	6.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAPK3—atherosclerosis	6.69e-06	6.59e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.66e-06	6.57e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—atherosclerosis	6.49e-06	6.4e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOB—atherosclerosis	6.38e-06	6.29e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.21e-06	6.12e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—LPL—atherosclerosis	6.09e-06	6.01e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—atherosclerosis	6.03e-06	5.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—atherosclerosis	5.95e-06	5.86e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CD36—atherosclerosis	5.79e-06	5.71e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.49e-06	5.41e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARA—atherosclerosis	5.38e-06	5.31e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AGT—atherosclerosis	5.21e-06	5.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—atherosclerosis	5.11e-06	5.03e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—atherosclerosis	5.06e-06	4.99e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOA1—atherosclerosis	5.05e-06	4.98e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6—atherosclerosis	4.89e-06	4.82e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.61e-06	4.54e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—atherosclerosis	4.51e-06	4.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPARG—atherosclerosis	4.45e-06	4.39e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—INS—atherosclerosis	4.36e-06	4.3e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—atherosclerosis	4e-06	3.94e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—atherosclerosis	3.83e-06	3.77e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.5e-06	3.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—atherosclerosis	1.76e-06	1.73e-05	CbGpPWpGaD
